Loreal, FR0000120321

Loreal stock heads into the open after a 0.9% gain

Published on 09/14/2026 at 04:45 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

At the close on September 11, 2026, Loreal stock finished at EUR 388.50 on Euronext Paris, up 0.9%. The session tracked a stronger move in the CAC 40 index and followed legal headlines about an Arizona lawsuit over hair relaxer products.

Stack of new unbranded passenger car tires with detailed tread pattern in automotive showroom
Michelin FR0000120321 Reifenhersteller zeigt gestapelte neue Pkw-Neureifen mit Profilmuster im modernen Showroom, Illustration mit AI erstellt.

Loreal stock closed at EUR 388.50 on Euronext Paris on September 11, 2026, rising 0.9% from the prior session per Euronext data cited by TradingView. The move came as the CAC 40 index also advanced on September 11, 2026, providing a supportive backdrop for large French blue chips.

September 11, 2026 in numbers

Loreal SA (ISIN FR0000120321, Euronext Paris: OR) ended the September 11, 2026 session at EUR 388.50, within its intraday range that kept the close near the upper end of the day’s trading band per Euronext figures. The 0.9% daily gain compared with a roughly 0.8% rise in the CAC 40 on September 11, 2026, so the shares slightly outperformed the French benchmark. Trading volume on Euronext Paris for Loreal on September 11, 2026 was consistent with recent averages, indicating steady investor interest without an unusually heavy turnover spike.

The legal backdrop also drew attention. As Reuters reported on September 11, 2026, Arizona authorities filed a lawsuit accusing Loreal of concealing cancer risks linked to certain hair relaxer products, keeping regulatory and litigation issues in focus for the stock. A summary of the allegations was echoed in a later note from The Fly, underlining that legal risks remain part of the investment narrative even as the share price advanced in the last session.

Today’s focus on legal risk and sector signals

Today, September 14, 2026, investors are set to monitor follow-up developments around the Arizona lawsuit and any potential company response or regulatory commentary that could alter the risk profile for Loreal. The case, detailed by Reuters, centers on alleged health risks from hair relaxer products, a theme that can influence sentiment toward cosmetics and personal care names more broadly.

Sector signals also matter heading into today’s European session. Recent commentary on beauty and personal care peers, including a discussion of brand campaigns highlighted by Simply Wall St, keeps attention on marketing momentum and consumer demand trends in the segment. Against this backdrop, any new regulatory, legal or consumer data points today could influence how Loreal shares trade once the market opens.

Disclaimer...

en | FR0000120321 | LOREAL | boerse | 70096342 | bgmi